...
首页> 外文期刊>The Journal of Organic Chemistry >Stereoselective synthesis of (S)-3-(methylamino)-3-((R)-pyrrolidin-3-yl) propanenitrile
【24h】

Stereoselective synthesis of (S)-3-(methylamino)-3-((R)-pyrrolidin-3-yl) propanenitrile

机译:立体选择性合成(S)-3-(甲基氨基)-3-((R)-吡咯烷-3-基)丙烷腈

获取原文
获取原文并翻译 | 示例
           

摘要

S)-3-(Methylamino)-3-((R)-pyrrolidin-3-yl)propanenitrile (1) is a key intermediate in the preparation of PF-00951966,(1) a fluoroquinolone antibiotic for use against key pathogens causing community-acquired respiratory tract infections including multidrug resistant (MDR) organisms. The current work describes the development of a highly efficient and stereoselective synthesis of 1 in 10 steps with an overall yield of 24% from readily available benzyloxyacetyl chloride. Two key transformations in the synthetic sequence involve (a) catalytic asymmetric hydrogenation with chiral DM-SEGPHOS-Ru(II) complex to afford β-hydroxy amide 11b in good yield (73%) and high stereoselectivity (de 98%, ee <99%) after recrystallization and (b) S _N2 substitution reaction with methylamine to provide diamine 14 with inversion of configuration at the 1′-position in high yield (80%), after efficient purification using a simple acid/base extraction protocol.
机译:S)-3-(甲基氨基)-3-((R)-吡咯烷-3-基)丙腈(1)是制备PF-00951966的关键中间体,(1)氟喹诺酮类抗生素,用于对抗引起关键病原体社区获得性呼吸道感染,包括耐多药(MDR)生物。目前的工作描述了一种高效,立体选择性的合成方法,该方法以十分容易的方式在10个步骤中合成1个化合物,从容易获得的苄氧基乙酰氯中获得的总收率为24%。合成序列中的两个关键转化包括(a)用手性DM-SEGPHOS-Ru(II)络合物催化不对称氢化,以高收率(73%)和高立体选择性(de 98%,ee <99重结晶和(b)与甲胺进行S_N2取代反应后,在使用简单的酸/碱萃取方案进行有效提纯后,可以高产率(80%)提供二胺14的1'-位构型反转。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号